The award from the latest round of CARB-X funding will help the company evaluate the potential of a prototype assay that can ...

The following is a summary of “Multidisciplinary Center Care for Long COVID Syndrome–A Retrospective Cohort Study,” published in the January 2025 issue of Pulmonology by Bailey et al. Researchers ...

The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...

COVID-19 isn't just a respiratory illness — it can silently attack the heart. New research reveals that the virus accelerates ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

A new study linked COVID-19 with the rapid growth of plaque in the coronary arteries. This plaque is a high-risk type prone ...

This prospective case-control study included 85 patients with lung involvement related to the COVID-19 virus and a group of ...

A new study found severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was associated with the rapid growth ...

The adenovirus carries the SARS-CoV-2 protein into the nose ... the nasal vaccine entirely prevented infection from taking hold in the nose and lungs — suggesting that vaccinated individuals would be ...

The virus was linked with the rapid growth of plaque in the coronary arteries which increases the chances of major ...